Cargando…
Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement: Frequency, Clinical-Pathologic Characteristics, and Response to ALK Inhibitor()
PURPOSE: The incidence of anaplastic lymphoma kinase (ALK) rearrangement in pulmonary sarcomatoid carcinoma (PSC) is controversial. In this study, we aimed to reveal the reliable frequency and the clinical-pathologic characteristics of pulmonary sarcomatoid carcinoma (PSC) with ALK rearrangement in...
Autores principales: | Chen, Xinru, Zhang, Yu, Lu, Jiabin, Xu, Chunwei, Liang, Jianzhong, Wang, Fang, Sun, Wenyong, Fang, Sangao, Yuan, Jingping, Wang, Huijuan, Wang, Hui, Liu, Xuewen, Chen, Likun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225784/ https://www.ncbi.nlm.nih.gov/pubmed/28081478 http://dx.doi.org/10.1016/j.tranon.2016.11.009 |
Ejemplares similares
-
ALK1 Gene Rearranged Pulmonary Sarcomatoid Carcinoma Masquerading as Tuberculosis in a Young Male
por: Sahay, Ayushi, et al.
Publicado: (2021) -
Poor prognosis of pulmonary sarcomatoid carcinoma with KRAS mutation and ALK fusion
por: Chen, Fangmin, et al.
Publicado: (2019) -
Response to ALK‐TKIs in a lung adenocarcinoma patient harboring dual
DCTN1‐ALK
and
ALK‐CLIP4
rearrangements
por: Gao, Fangfang, et al.
Publicado: (2022) -
Frequency of ALK Rearrangement by FISH Testing and its Correlation with ALK-IHC in Adenocarcinoma of Primary Lung Origin
por: Moatter, Samar, et al.
Publicado: (2018) -
Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors
por: Takeyasu, Yuki, et al.
Publicado: (2021)